Sudanese RVF (rift valley fever) crisis worsens, adding to diagnostic challenge:
This article was originally published in Clinica
The number of cases of rift valley fever (RVF) in Sudan has increased rapidly since outbreaks were first detected in late October, now posing further diagnostic surveillance challenges. By November 14, 329 cases and 96 deaths had been recorded across the states of Gazeera, West Nile, Sinnar and Khartoum, according to the WHO. There has, however, been no update on the results of confirmatory testing said to rely on PCR (polymerase chain reaction) and ELISA (enzyme-linked immuno-sorbent assay) laboratory support. By November 7, 25 positives had been confirmed using these; three cases in Khartoum were then confirmed as negative, though new "imported" cases are being reported. Laboratory support is being provided primarily by the Cairo, Egypt-based WHO collaborating centre for emerging infectious diseases, NAMRU-3.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.